Reset
Id
Protein
PTM type
Site
Species
Disease
Celline
Drug
Regulatory
Confidence score(level)
Ref.
acc01251 Histone H2B type 3-B oxidation Met63 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01252 U5 small nuclear ribonucleoprotein 200 kDa helicase oxidation Met229 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01253 Large ribosomal subunit protein P1 oxidation Met108 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01254 Large ribosomal subunit protein P2 oxidation Met109 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01255 Retinoblastoma-associated protein oxidation Met825 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01256 Nucleophosmin oxidation Met65 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01257 DNA topoisomerase 2-alpha oxidation Met1328 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01258 Nucleolin oxidation Met33 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01259 14-3-3 protein theta oxidation Met218 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01260 14-3-3 protein beta/alpha oxidation Met220 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01261 "14-3-3 protein beta/alpha, N-terminally processed" oxidation Met220 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01262 14-3-3 protein sigma oxidation Met223 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01263 14-3-3 protein gamma oxidation Met221 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01264 "14-3-3 protein gamma, N-terminally processed" oxidation Met223 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01265 14-3-3 protein epsilon oxidation Met218 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01266 General transcription factor IIF subunit 1 oxidation Met216 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01267 Microtubule-associated protein 1B oxidation Met1645 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01268 Microtubule-associated protein 1B oxidation Met830 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01269 Double-strand break repair protein MRE11 oxidation Met698 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01270 Microfibrillar-associated protein 1 oxidation Met127 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01271 "Actin, cytoplasmic 2" oxidation Met325 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01272 "Actin, cytoplasmic 2, N-terminally processed" oxidation Met325 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01273 "Actin, cytoplasmic 1" oxidation Met327 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01274 "Actin, cytoplasmic 1, N-terminally processed" oxidation Met327 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01275 "Actin, alpha skeletal muscle" oxidation Met326 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01276 "Actin, alpha skeletal muscle, intermediate form" oxidation Met327 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01277 Histone H4 oxidation Met85 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01278 Transformer-2 protein homolog beta oxidation Met208 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01279 "Actin, alpha skeletal muscle" oxidation Met84 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01280 "Actin, alpha skeletal muscle, intermediate form" oxidation Met84 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01281 "Actin, alpha cardiac muscle 1" oxidation Met83 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01282 "Actin, alpha cardiac muscle 1, intermediate form" oxidation Met84 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01283 CCAAT/enhancer-binding protein zeta oxidation Met644 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01284 TP53-binding protein 1 oxidation Met1107 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01285 Histone deacetylase 1 oxidation Met381 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01286 SNW domain-containing protein 1 oxidation Met230 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01287 Bystin oxidation Met93 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01288 Prostaglandin E synthase 3 oxidation Met126 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01289 Prostaglandin E synthase 3 oxidation Met127 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01290 Prostaglandin E synthase 3 oxidation Met130 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01291 Protein FAM133B oxidation Met147 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01292 ATP-dependent RNA helicase DDX42 oxidation Met164 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01293 Pre-mRNA-splicing factor 38A oxidation Met188 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01294 Protein LSM14 homolog A oxidation Met195 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01295 Histone deacetylase 2 oxidation Met373 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01296 Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 oxidation Met106 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01297 Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 oxidation Met108 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01298 Synembryn-A oxidation Met426 human Lung Cancer PC9IR Gefitinib Negative 4.0 (Moderate) PXD000861
acc01299 WD repeat-containing protein 70 oxidation Met632 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861
acc01300 Serine/arginine repetitive matrix protein 2 oxidation Met1396 human Lung Cancer PC9IR Gefitinib Positive 4.0 (Moderate) PXD000861